drug
(chlorpheniramine maleate + codeine) ER
Marketedupdated 4mo agoby MainPointe Pharmaceuticals LLC
Approvedcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
Patent cliff
source: FDA Orange Bookfirst barrier falls
Jan 3, 2032
~5.3 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (2)
- Jan 3, 2032method-of-use (U-1716)US 9066942
- Jan 3, 2032formulationUS 9107921
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 5m ago
Found something off?
comments(0)
5-min edit window · permanent after that